XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Comprehensive Income - EUR (€)
€ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Statement of comprehensive income [abstract]      
Net income € 3,456 € 3,237 € 8,484
Attributable to equity holders of Sanofi 3,430 3,184 8,371
Attributable to non-controlling interests 26 53 113
Other comprehensive income:      
Actuarial gains/(losses) 141 1,110 654
Change in fair value of equity instruments included in financial assets and financial liabilities 3 13 13
Tax effects (59) (336) (216)
Items not subsequently reclassifiable to profit or loss 85 787 451
Change in fair value of debt instruments included in financial assets 6 (52) (77)
Change in fair value of cash flow hedges 1 (17) 7
Change in currency translation differences (1,057) 3,435 2,278
Tax effects (8) 97 105
Items subsequently reclassifiable to profit or loss (1,058) 3,463 2,313
Other comprehensive income for the period, net of taxes (973) 4,250 2,764
Comprehensive income 2,483 7,487 11,248
Attributable to equity holders of Sanofi 2,465 7,415 11,130
Attributable to non-controlling interests € 18 € 72 € 118